Fundz

Lusaris Therapeutics reported raising $60.2 Million in an initial SEC Form D filing, from an offering of $60.2 Million

PRIVATEDec 06, 2022

Amount Raised

$60.2 Million

$60.2 Million sold, per SEC Form D (first sale Oct 13, 2022)

Round Type

Venture

MorrisvilleHealthcareTherapeutics

Quick answer

Lusaris Therapeutics raised $60.2 Million in a funding round, dated October 13, 2022. Lusaris Therapeutics is based in Morrisville, North Carolina, United States.

How much did Lusaris Therapeutics raise?
Lusaris Therapeutics raised $60.2 Million in a funding round on October 13, 2022.
What does Lusaris Therapeutics do?
Lusaris is a biotechnology company advancing next-generation serotonergic neuroplastogen therapeutics to treat severe neuropsychiatric and neurological disorders.
Where is Lusaris Therapeutics based and how big is it?
Lusaris Therapeutics is based in Morrisville, North Carolina, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Lusaris Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Parabilis Medicines raised $178M (Series D) on November 21, 2022.
  • Parabilis Medicines raised $178M on November 17, 2022.
  • Phio Pharmaceuticals raised $2K (Seed) on November 16, 2022.
  • Os Therapies raised $2M on November 16, 2022.
  • Renibus Therapeutics raised $33M (Funding Round) on November 14, 2022.
  • Curavit Clinical Research raised $5M (Series A) on November 14, 2022.

Who to call at Lusaris Therapeutics, and when

A new round usually means Lusaris Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lusaris Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lusaris Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lusaris Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lusaris Therapeutics

Location

630 Davis Drive, Suite 220

Morrisville, North Carolina, United States

About

Lusaris is a biotechnology company advancing next-generation serotonergic neuroplastogen therapeutics to treat severe neuropsychiatric and neurological disorders. Our lead program, LSR-1019, is a proprietary sublingual formulation of 5-MeO-DMT, a rapidly acting and rapidly clearing serotonergic psychedelic in development for treatment-resistant depression and other neuropsychiatric conditions. In addition to LSR-1019, our pipeline includes novel neuroplastogens for a wide range of neuropsychiatric and neurological conditions including migraine and cluster headache.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lusaris Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lusaris Therapeutics's next move

See what Strategic adds

Lusaris Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.